Furthermore, AD regulates the Th1/Th2 immune balance in advanced colorectal cancer sufferers, increasing serum levels of prealbumin, IgA, and IgG, thereby effectively improving the patient’s immune status (134, 135). The gene discussed is CD79A; the disease is colorectal cancer.